Janney Capital upgraded Bio-Techne (NASDAQ: TECH) from Buy to Neutral with a price target of $100.00 (from $118.00).

For an analyst ratings summary and ratings history on Bio-Techne click here. For more ratings news on Bio-Techne click here.

Shares of Bio-Techne closed at $95.94 yesterday.